Neopharmed Gentili

News

Neopharmed Gentili buys BioCryst's hereditary angioedema drug Orladeyo in Europe, the first stage of an international expansion for the Italian firm.

News

Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3bn, Parabilis has joined the IPO queue.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.